MATTHEW JAMES BUTLER
Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology SAN ANTONIO, TX NPI 1013297167
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology TX BeiGene USA, Inc. All categories
General Payments — all program years on this page
$39,334.81
- Category: General Payments
- Program years: PY2018–2024
- Record count: 56
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $3,091.37 across 6 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $2,775.00 | 2 |
| Food and Beverage | $298.28 | 3 |
| Education | $18.09 | 1 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| BeiGene USA, Inc. | $2,280.11 | 2 |
| Acerta Pharma LLC | $525.00 | 1 |
| GENZYME CORPORATION | $143.18 | 1 |
| Karyopharm Therapeutics Inc. | $124.99 | 1 |
| Merck Sharp & Dohme Corporation | $18.09 | 1 |
By program year
Records — PY2024 (6)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1104197483 | AstraZeneca Pharmaceuticals LP | $525.00 | 10/24/2024 | Consulting Fee | Undisputed | 01/23/2026 | View at CMS |
| 1120861803 | BeiGene USA, Inc. | $2,250.00 | 12/06/2024 | Consulting Fee | Undisputed | 01/23/2026 | View at CMS |
| 1120861805 | BeiGene USA, Inc. | $30.11 | 09/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1139874348 | GENZYME CORPORATION | $143.18 | 04/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1141563799 | Merck Sharp & Dohme LLC | $18.09 | 02/12/2024 | Education | Undisputed | 01/23/2026 | View at CMS |
| 1145533436 | Karyopharm Therapeutics Inc. | $124.99 | 10/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.